Code Bio

Code Bio is developing a transformational, new class of precision genetic medicines to treat life-threatening diseases, leveraging its proprietary, novel, multivalent, synthetic DNA delivery platform, 3DNA®

Biotech & Life Sciences

Sector

Seed

Stage

Biotechnology research

Model

01Company Overview

Code Bio is developing a transformational, new class of precision genetic medicines to treat life-threatening diseases, leveraging its proprietary, novel, multivalent, synthetic DNA delivery platform, 3DNA®.

02Backed By1 investor

HVHatteras Venture Partners→

03Similar Companies